MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.9900
0.00 (0.00%)
At close: Jan 16, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 4.75 million as of January 20, 2026. Its market cap has increased by 42.69% in one year.
Market Cap
4.75M
Enterprise Value
6.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.99
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 4.75M, a decrease of -94.05%. That is a compound annual growth rate of -64.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 5.28M | -11.95% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.15B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 2.02B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |